多结局聚类生存数据的多水平随机效应模型
本文提出一种多水平脆弱模型,用于处理具有多水平结构(受试者聚类与多个失败结局)的生存数据中的序列相关性和同时异质性。模型通过引入随机协变量和不可观测的随机机构效应,分别处理治疗-by-机构交互作用和基线风险的机构间变异,并附加一阶自回归相关结构的随机效应项以估计患者间异质性和序列依赖性。采用广义线性混合模型方法,假设随机效应分布为正态,扩展残差最大似然和最大似然法估计参数,并通过模拟研究评估估计器性能和随机效应分布误设的影响,最后分析囊性纤维化患者中rhDNase对呼吸加重影响的双盲随机多机构临床试验数据。
要点
- 多水平脆弱模型可同时处理聚类和多个失败结局的生存数据。
- 随机协变量和随机机构效应分别处理治疗-by-机构交互和机构间基线风险变异。
- 一阶自回归随机效应项用于估计患者间异质性和序列依赖性。
核心结论
- 提出的多水平脆弱模型能有效处理多水平结构生存数据中的序列依赖和同时异质性。
研究设计与样本
- 方法学论文,通过模拟研究评估残差最大似然和最大似然估计器性能,并分析双盲随机多机构临床试验数据。
主要发现
- 模拟研究评估了残差最大似然和最大似然估计器的性能及随机效应分布误设对推断的影响。
- 通过分析囊性纤维化患者中rhDNase对呼吸加重影响的试验数据,证明了建模方法的实际可行性。
临床怎么用
- 该方法可用于分析多机构临床试验中具有重复发作和多个失败结局的生存数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We present a multilevel frailty model for handling serial dependence and simultaneous heterogeneity in survival data with a multilevel structure attributed to clustering of subjects and the presence of multiple failure outcomes. One commonly observes such data, for example, in multi-institutional, randomized placebo-controlled trials in which patients suffer repeated episodes (eg, recurrent migraines) of the disease outcome being measured. The model extends the proportional hazards model by incorporating a random covariate and unobservable random institution effect to respectively account for treatment-by-institution interaction and institutional variation in the baseline risk. Moreover, a random effect term with correlation structure driven by a first-order autoregressive process is attached to the model to facilitate estimation of between patient heterogeneity and serial dependence. By means of the generalized linear mixed model methodology, the random effects distribution is assumed normal and the residual maximum likelihood and the maximum likelihood methods are extended for estimation of model parameters. Simulation studies are carried out to evaluate the performance of the residual maximum likelihood and the maximum likelihood estimators and to assess the impact of misspecifying random effects distribution on the proposed inference. We demonstrate the practical feasibility of the modeling methodology by analyzing real data from a double-blind randomized multi-institutional clinical trial, designed to examine the effect of rhDNase on the occurrence of respiratory exacerbations among patients with cystic fibrosis.
引用
- Tawiah R, Yau KKW, McLachlan GJ, et al. Multilevel model with random effects for clustered survival data with multiple failure outcomes. Stat Med. 2018. PMID: 30474216. doi:10.1002/sim.8041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。